CVS Health (CVS)
Market Price (9/13/2025): $74.86 | Market Cap: $94.4 BilSector: Health Care | Industry: Health Care Services
CVS Health (CVS)
Market Price (9/13/2025): $74.86Market Cap: $94.4 BilSector: Health CareIndustry: Health Care Services
Investment Highlights
Attractive yieldTotal YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 9.2%, Dividend Yield is 3.6%, ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is 4.7%, FCF Yield is 6.3% | Trading close to highsDist 52W High is 0.0% | Debt is significantNet D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is 73% |
Attractive cash flow generationCFO LTM is 8.8 Bil, FCF LTM is 5.9 Bil | Weak multi-year price returns2Y Excs Rtn is -24%, 3Y Excs Rtn is -82% | |
Low stock price volatilityVol 12M is 38% |
Attractive yieldTotal YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 9.2%, Dividend Yield is 3.6%, ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is 4.7%, FCF Yield is 6.3% |
Attractive cash flow generationCFO LTM is 8.8 Bil, FCF LTM is 5.9 Bil |
Low stock price volatilityVol 12M is 38% |
Trading close to highsDist 52W High is 0.0% |
Weak multi-year price returns2Y Excs Rtn is -24%, 3Y Excs Rtn is -82% |
Debt is significantNet D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is 73% |
Market Valuation
9/13/25 | 2024 | 2023 | 2022 | 2021 | |
---|---|---|---|---|---|
Share Price CYE | $74.86 | $43.40 | $73.28 | $83.78 | $90.69 |
Market Cap CYE ($ Bil) | 94.4 | 54.8 | 94.4 | 109.7 | 119.9 |
Total Debt ($ Bil) | 81.2 | 82.9 | 79.4 | 70.7 | 76.0 |
Total Cash ($ Bil) | 12.7 | 11.0 | 11.5 | 15.7 | 12.5 |
Enterprise Value ($ Bil) | 163.0 | 137.7 | 173.8 | 180.4 | 195.9 |
Valuation Ratios | |||||
P/S TTM | 0.2 | 0.1 | 0.3 | 0.4 | 0.5 |
P/EBIT TTM | 9.2 | 6.2 | 7.3 | 15.1 | 10.4 |
P/E TTM | 17.9 | 12.2 | 12.2 | 28.4 | 17.0 |
Sector Ratios | |||||
P/S TTM (Sector) | 3.8 | 3.6 | 4.1 | 4.5 | 7.3 |
P/EBIT TTM (Sector) | -1.6 | -1.3 | -1.4 | -1.3 | -2.9 |
P/E TTM (Sector) | -1.9 | -1.6 | -1.5 | -1.4 | -2.9 |
9/13/25 | 2024 | 2023 | |
---|---|---|---|
Share Price CYE | $74.86 | $43.40 | $73.28 |
Market Cap CYE ($ Bil) | 94.4 | 54.8 | 94.4 |
Total Debt ($ Bil) | 81.2 | 82.9 | 79.4 |
Total Cash ($ Bil) | 12.7 | 11.0 | 11.5 |
Enterprise Value ($ Bil) | 163.0 | 137.7 | 173.8 |
Valuation Ratios | |||
P/S TTM | 0.2 | 0.1 | 0.3 |
P/EBIT TTM | 9.2 | 6.2 | 7.3 |
P/E TTM | 17.9 | 12.2 | 12.2 |
Sector Ratios | |||
P/S TTM (Sector) | 3.8 | 3.6 | 4.1 |
P/EBIT TTM (Sector) | -1.6 | -1.3 | -1.4 |
P/E TTM (Sector) | -1.9 | -1.6 | -1.5 |
Business Description
CVS Health Corporation provides health services in the United States. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates.
Show more
Price Returns Compared
Expand for Detailed View2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Total [1] | |
---|---|---|---|---|---|---|---|
Returns | |||||||
CVS Return | -5% | 55% | -8% | -13% | -41% | 72% | 20% |
Peers Return | 25% | 24% | -22% | 14% | 18% | -20% | 31% |
S&P 500 Return | 16% | 27% | -19% | 24% | 23% | 12% | 101% |
[1] Cumulative total returns since the beginning of 2020
[2] Peers: AMZN, WMT, KR, TGT, WBA. See CVS Returns vs. Peers.
[3] 2025 data is for the year up to 9/12/2025 (YTD)
Latest Trefis Analyses
Research & Analysis
Invest in Strategies
Wealth Management
Peer Comparisons for CVS Health
Financials
Median | |
---|---|
Name | |
Mkt Price | 89.96 |
Mkt Cap | 69.8 |
Rev LTM | 266,770 |
Op Inc LTM | 8,161 |
FCF LTM | 4,442 |
FCF 3Y Avg | 6,886 |
CFO LTM | 7,573 |
CFO 3Y Avg | 10,352 |
Growth & Margins
Median | |
---|---|
Name | |
Rev Chg LTM | 4.6% |
Rev Chg 3Y Avg | 5.2% |
Rev Chg Q | 5.9% |
QoQ Delta Rev Chg LTM | 1.4% |
Op Mgn LTM | 3.5% |
Op Mgn 3Y Avg | 3.9% |
QoQ Delta Op Mgn LTM | 0.0% |
CFO/Rev LTM | 4.7% |
CFO/Rev 3Y Avg | 4.8% |
FCF/Rev LTM | 1.8% |
FCF/Rev 3Y Avg | 2.7% |
Valuation
Median | |
---|---|
Name | |
Mkt Cap | 69.8 |
P/S | 0.3 |
P/EBIT | 10.6 |
P/E | 17.7 |
P/CFO | 9.4 |
Total Yield | 5.6% |
Dividend Yield | 1.4% |
FCF Yield 3Y Avg | 4.2% |
D/E | 0.3 |
Net D/E | 0.2 |
Returns
Median | |
---|---|
Name | |
1M Rtn | 1.6% |
3M Rtn | 7.6% |
6M Rtn | 15.3% |
12M Rtn | 26.2% |
3Y Rtn | 47.9% |
1M Excs Rtn | -0.2% |
3M Excs Rtn | -1.9% |
6M Excs Rtn | -2.8% |
12M Excs Rtn | 12.8% |
3Y Excs Rtn | -18.8% |
Comparison Analyses
Segment Financials
Revenue by Segment
$ Mil | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Health Services | 186,843 | 169,576 | 153,892 | 132,663 | 130,428 |
Pharmacy & Consumer Wellness | 116,763 | 108,596 | 101,620 | 60,208 | 56,258 |
Health Care Benefits | 105,646 | 91,350 | 82,119 | 75,409 | 69,578 |
Corporate/Other | 451 | 530 | 721 | 426 | 512 |
Intersegment Eliminations | -51,927 | -47,585 | -46,241 | ||
Total | 357,776 | 322,467 | 292,111 | 268,706 | 256,776 |
$ Mil | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Health Services | 7,312 | 6,781 | 6,492 | 5,454 | 4,735 |
Pharmacy & Consumer Wellness | 5,963 | 6,531 | 7,260 | 5,640 | 5,793 |
Health Care Benefits | 5,577 | 6,338 | 5,110 | 5,166 | 3,639 |
Office real estate optimization charges | -46 | -117 | 0 | ||
Loss on Accountable Care assets | -349 | -2,533 | 0 | ||
Acquisition-related integration costs | -487 | -132 | |||
Net realized capital losses | -497 | -320 | 176 | ||
Restructuring charge | -507 | 0 | |||
Corporate/Other | -1,318 | -1,613 | -1,635 | -1,641 | -1,483 |
Amortization of intangible assets | -1,905 | -1,785 | -2,233 | ||
Gain on divestiture of subsidiary | 475 | 0 | |||
Omnicare litigation charge | -5,803 | 0 | |||
Acquisition purchase price adjustment outside of measurement period | 61 | ||||
Goodwill impairment | -431 | ||||
Intersegment Eliminations | 0 | -708 | -697 | ||
Store impairments | -1,358 | ||||
Total | 13,743 | 7,954 | 13,310 | 13,911 | 11,987 |
Returns Analyses
Earnings Returns History
Expand for MoreForward Returns | |||
---|---|---|---|
Earnings Date | 1D Returns | 5D Returns | 21D Returns |
7/31/2025 | -0.3% | 2.0% | 15.8% |
5/1/2025 | 4.1% | 0.1% | -4.0% |
2/12/2025 | 14.9% | 20.7% | 19.5% |
10/18/2024 | -5.2% | -10.9% | -15.5% |
8/7/2024 | -3.2% | -4.3% | -0.5% |
5/1/2024 | -16.8% | -17.7% | -17.2% |
2/7/2024 | 3.1% | 3.8% | 0.7% |
11/1/2023 | -0.4% | 1.8% | -1.5% |
... | |||
SUMMARY STATS | |||
# Positive | 13 | 17 | 13 |
# Negative | 12 | 8 | 12 |
Median Positive | 4.8% | 3.5% | 8.7% |
Median Negative | -3.1% | -4.7% | -6.2% |
Max Positive | 14.9% | 20.7% | 19.9% |
Max Negative | -16.8% | -17.7% | -26.1% |
SEC Filings
Expand for MoreReport Date | Filing |
---|---|
6302025 | 10-Q 6/30/2025 |
3312025 | 10-Q 3/31/2025 |
12312024 | 10-K 12/31/2024 |
9302024 | 10-Q 9/30/2024 |
6302024 | 10-Q 6/30/2024 |
3312024 | 10-Q 3/31/2024 |
12312023 | 10-K 12/31/2023 |
9302023 | 10-Q 9/30/2023 |
6302023 | 10-Q 6/30/2023 |
3312023 | 10-Q 3/31/2023 |
12312022 | 10-K 12/31/2022 |
9302022 | 10-Q 9/30/2022 |
6302022 | 10-Q 6/30/2022 |
3312022 | 10-Q 3/31/2022 |
12312021 | 10-K 12/31/2021 |
9302021 | 10-Q 9/30/2021 |
Insider Activity
Expand for MoreOwner | Title | Filing Date | Action | Price | Shares | TransactedValue | Value ofHeld Shares | Form | |
---|---|---|---|---|---|---|---|---|---|
0 | Finucane Anne A. | 8292025 | Sell | 71.02 | 7,500 | 532,650 | 1,573,519 | Form | |
1 | SANSONE GUY P | 6092025 | Buy | 63.70 | 1,570 | 100,009 | 764,869 | Form | |
2 | ROBBINS LARRY | 5062025 | Sell | 67.39 | 1,679,736 | 113,190,186 | 691,853,227 | Form | |
3 | Mahoney Michael F | 2192025 | Buy | 66.70 | 30,000 | 2,001,000 | 2,625,045 | Form |
External Quote Links
Y Finance | Barrons |
TradingView | Morningstar |
SeekingAlpha | ValueLine |
Motley Fool | Robinhood |
CNBC | Etrade |
MarketWatch | Unusual Whales |
YCharts | Perplexity Finance |
FinViz |